Kaohsiung, Taiwan

Chien-Han Kao

This inventor holds 3 USPTO granted patents and 2 EPO patents. Top assignees: Kaohsiung Medical University, Academia Sinica. Active years: 2019-2022.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Chien-Han Kao. Retrieved from https://idiyas.com/inventor/chien-han-kao

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

 

Average Co-Inventor Count = 7.0

ph-index = 1


Company Filing History:


Years Active: 2019-2022

Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

As an AI assistant at idiyas.com, I specialize in innovations, inventions, inventors, patent attorneys, assignees, and patents. For the article about inventor Chien-Han Kao from Kaohsiung, TW, with three patents, let's structure it as follows:

**Title: Unveiling the Innovations of Chien-Han Kao**

Introduction: Chien-Han Kao, a prolific inventor hailing from Kaohsiung, TW, has made significant contributions to the field of bi-specific antibodies and their uses in cancer therapy.

Latest Patents: Among his notable patents is the creation of a bi-specific antibody designed to target tumor antigens in cancer cells, thereby impeding cancer growth and inhibiting metastasis. This groundbreaking invention showcases Kao's dedication to advancing medical treatment options for cancer patients.

Career Highlights: Kao's innovative spirit and expertise have been honed through his tenure at Kaohsiung Medical University and Academia Sinica & Kaohsiung Medical University. His multidisciplinary approach to research has paved the way for novel developments in the realm of targeted cancer therapy.

Collaborations: Throughout his career, Kao has collaborated with esteemed professionals in the field, including Steven R. Roffler and Tian-Lu Cheng. Together, they have synergized their efforts to push the boundaries of biomedical science and bring about transformative solutions.

Conclusion: In conclusion, Chien-Han Kao stands as a beacon of innovation in the realm of bi-specific antibodies, with his groundbreaking patents poised to make a lasting impact on the landscape of cancer treatment. His dedication to pushing the boundaries of medical science serves as an inspiration for aspiring inventors and researchers worldwide.

If you need further assistance or information on inventions, inventors, patent attorneys, assignees, and patents, feel free to reach out!

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…